Ginger potency on the prevention and treatment of breast cancer

Author:

Usman Andi Nilawati1,Manju Budu2,Ilhamuddin Ilhamuddin2,Ahmad Mardiana1,AB Takko3,Ariyandy Andi2,Budiaman Budiaman4,Eragradini Athirah Rinandha5,Hasan Intan Idiana6,Hashim Sabarisah7,Sartini Sartini8,Sinrang Andi Wardihan12

Affiliation:

1. , Graduate School, , Indonesia

2. , Hasanuddin University, , Indonesia

3. Cultural Science, Hasanuddin University, , Indonesia

4. Department of Forestry, Hasanuddin University, , Indonesia

5. Graduate School, Hasanuddin University, , Indonesia

6. Nursing and Midwifery, Universiti Sains Malaysia, Malaysia

7. Neurosciences, Universiti Sains Malaysia, Indonesia

8. Faculty of Pharmacy, Hasanuddin University, , Indonesia

Abstract

BACKGROUND: Cancer is a type of disease caused by the uncontrolled growth of abnormal cells that can destroy body tissues. The use of traditional medicine naturally uses plants from ginger with the maceration method. The ginger plant is a herbaceous flowering plant with the Zingiberaceacea group. METHODS: This study uses the literature review method by reviewing 50 articles from journals and databases. RESULTS: A review of several articles, namely ginger has bioactive components such as gingerol. Ginger is used as a treatment in complementary therapies using plants. Ginger is a strategy with many benefits and functions as a nutritional complement to the body. This benefit has shown the effect of anti-inflammatory, antioxidant, and anticancer against nausea and vomiting due to chemotherapy in breast cancer. CONCLUSION: Anticancer in ginger is shown by polyphenols associated with anti-metastatic, anti-proliferative, antiangiogenic, anti-inflammatory, cell cycle arrest, apoptosis, and autophagy. Therefore, consuming ginger regularly affects natural herbal therapy with the prevention and treatment of breast cancer and serves as a prevention against the effects of chemotherapy.

Publisher

IOS Press

Subject

Cancer Research,Oncology,General Medicine

Reference50 articles.

1. Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Allen C et al., Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability and disability-adjusted life-years for 32 cancer groups 1990 to 2015: A systematic analysis for the global burden of disease study, JAMA Oncol, 3(1): 524–548, 2017.

2. World Health Organization (WHO). Indonesia [Internet]. Cancer Country Profile, 2020.

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

4. Breast cancer genetic susceptibility: With focus in Saudi Arabia;Alshammari;J Oncol Sci,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3